Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2019/060770external-prioritypatent/WO2020102096A1/en
Application filed by Novartis AgfiledCriticalNovartis Ag
Publication of DOP2021000090ApublicationCriticalpatent/DOP2021000090A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
En un aspecto, se presentan compuestos de la Fórmula AA, o una de sus sales farmacéuticamente aceptables: Fórmula AA o una de sus sales farmacéuticamente aceptables, en donde las variables que se muestran en la Fórmula A pueden definirse como en cualquier lugar del presente documento.In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are presented: Formula AA or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A may be defined as elsewhere herein .
DO2021000090A2018-11-132021-05-11
COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH THE ACTIVITY OF NLRP
DOP2021000090A
(en)